Pharmaceuticals

Zydus Cadila seeks approval for its needle-free COVID vaccine ZyCOV-D; here's how it works

Another vaccine
AFP
1/5
Another vaccine
According to a TOI report, Ahmedabad-based Zydus Cadila, which is also one of the companies developing coronavirus vaccine, has sought emergency use approval for its three dose, needle-free COVID-19 vaccine, ZyCOV-D
How does it work
Getty Images
2/5
How does it work
ZyCoV-D is a plasmid DNA vaccine that uses a non-replicating version of a DNA molecule called plasmid, which helps prepare a harmless version of the spike protein present on the SARS-COV-2 membrane.
Three doses
New York Times
3/5
Three doses
Unlike the other COVID vaccines currently being administered in India, ZyCOV-D will be a three dose regimen. According to Zydus Cadila, the three doses of ZyCoV-D are to be administered on day 0, day 28, and day 56. Reportedly, the company is also working on a two-dose vaccine.
Going needle free
Getty Images
4/5
Going needle free
Unlike any other COVID vaccine, Zydus Cadila is currently seeking approval for its needle-free vaccine, which will use the ‘Jet Injector' technique to administer the three doses. Rather than injecting the drug by piercing into the skin, the vaccine will use high-pressure to inject the liquid directly through the upper layer of the skin and into the underlying tissues.
An older technique
Reuters
5/5
An older technique
While it may seem like a new discovery into the world of vaccines, it is an old technique, first demonstrated in 1866. This method of vaccination was also used during the 1960s for smallpox vaccination drives.
Open in App
Success
This article has been saved